Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells.
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells.
复制标题
DOI:
10.1111/cas.14637
复制
发表时间:
2020-11
期刊:
影响因子:
5.7
通讯作者:
Takahashi M
中科院分区:
文献类型:
--
作者:
Chen C;Enomoto A;Weng L;Taki T;Shiraki Y;Mii S;Ichihara R;Kanda M;Koike M;Kodera Y;Takahashi M
The actin‐binding protein Girdin is a hub protein that interacts with multiple proteins to regulate motility and Akt and trimeric G protein signaling in cancer cells. Girdin expression correlates with poor outcomes in multiple human cancers. However, those findings are not universal, as they depend on study conditions. Those data suggest that multiple aspects of Girdin function and its role in tumor cell responses to anticancer therapeutics must be reconsidered. In the present study, we found that Girdin is involved in DNA damage‐induced cancer cell apoptosis. An esophageal cancer cell line that exhibited high Girdin expression showed a marked sensitivity to UV‐mediated DNA damage compared to a line with low Girdin expression. When transcriptional activation of endogenous Girdin was mediated by an engineered CRISPR/Cas9 activation system, sensitivity to DNA damage increased in both stationary and migrating HeLa cancer cells. High Girdin expression was associated with dysregulated cell cycle progression and prolonged G1 and M phases. These features were accompanied by p53 activation, which conceivably increases cancer cell vulnerability to UV exposure. These data highlight the importance of understanding complex Girdin functions that influence cancer cell sensitivity to therapeutics. The present study suggests that Girdin overexpression perturbs cell cycle distribution with prolonged G1 and M phases and aberrant p53 activation, which leads to an increase in sensitivity to DNA damage. It also showed that the upregulation of the spindle checkpoint protein Mad2 in Girdin‐overexpressing cells could be involved in dysregulated cell cycle progression.
登录
查看更多内容
影响因子:
64.8
作者:
Konermann S;Brigham MD;Trevino AE;Joung J;Abudayyeh OO;Barcena C;Hsu PD;Habib N;Gootenberg JS;Nishimasu H;Nureki O;Zhang F
通讯作者:
Zhang F
影响因子:
4.8
作者:
Garcia-Marcos, Mikel;Jung, Barbara H.;Ghosh, Pradipta
通讯作者:
Ghosh, Pradipta
影响因子:
4.5
作者:
Choi, Jong-Sun;Kim, Kyung Hee;Choi, Yoon-La
通讯作者:
Choi, Yoon-La
DOI:
10.1038/nrc3958
发表时间:
2015-07
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Barker HE;Paget JT;Khan AA;Harrington KJ
通讯作者:
Harrington KJ
影响因子:
10.5
作者:
DI LEONARDO, A;LINKE, SP;WAHL, GM
通讯作者:
WAHL, GM